Inspire Medical Systems, Inc. filed a current report on November 2, 2026, announcing its financial results for the quarter ended September 30, 2026, and disclosing investor presentation materials to be used at meetings in November and December 2026.

Key Highlights

  • Reporting period: Financial results cover the quarter ended September 30, 2026.
  • Filing date: The current report was filed on November 2, 2026.
  • Press release attached: A press release dated November 2, 2026, was furnished as Exhibit 99.1 to the filing.
  • Investor presentation: Presentation materials dated November 2, 2026, were furnished as Exhibit 99.2, for use at investor and analyst meetings in November and December 2026.
  • Signed by CFO: The filing was signed by Matthew J. Osberg, Chief Financial Officer, on November 2, 2026.

Inspire Medical Systems Discloses Third-Quarter 2026 Financial Results and Investor Materials

Inspire Medical Systems, Inc. (NYSE:INSP), a medical device company headquartered in Golden Valley, Minnesota, filed this current report under Item 2.02 to announce results of operations and financial condition for the quarter ended September 30, 2026. The company develops and markets implantable neurostimulation systems designed to treat obstructive sleep apnea, and the quarterly earnings disclosure reflects ongoing reporting obligations tied to its listed common stock, which carries a par value of $0.001 per share.

According to the filing, the full text of the earnings press release is furnished as Exhibit 99.1 and incorporated by reference. Separately, under Item 7.01 (Regulation FD Disclosure), the company furnished investor and analyst presentation materials as Exhibit 99.2. The filing states that Inspire Medical Systems will be participating in various meetings with investors and analysts during November and December 2026, and those presentation materials are the same documents being used at those meetings.

The filing notes that the information reported under Items 2.02 and 7.01, including Exhibits 99.1 and 99.2, "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934," as stated in the current report. The filing was signed by Chief Financial Officer Matthew J. Osberg on November 2, 2026, on behalf of Inspire Medical Systems, Inc., a Delaware corporation with Commission File Number 001-38468.

What Was Disclosed

Inspire Medical Systems filed a current report on November 2, 2026, furnishing its third-quarter 2026 earnings press release and an investor presentation as exhibits. The materials relate to the quarter ended September 30, 2026, and to planned investor meetings through December 2026.